Genmab Logo

Genmab

GMAB | CO

Overview

Corporate Details

ISIN(s):
DK0010272202 (+2 more)
LEI:
529900MTJPDPE4MHJ122
Country:
Denmark
Address:
Carl Jacobsens Vej 30, 2500 Valby
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other serious diseases. The company leverages its proprietary antibody technology platforms to pioneer and develop next-generation treatments. Through a combination of strategic partnerships and an expanding in-house pipeline, Genmab has successfully contributed to multiple approved medicines, focusing on transforming patient outcomes with its innovative science.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Genmab. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 20:36
Share Issue/Capital Change
English 175.2 KB
2025-08-12 20:36
Share Issue/Capital Change
English 7.8 KB
2025-08-07 17:08
Earnings Release
English 17.2 KB
2025-08-07 17:08
Earnings Release
English 741.7 KB
2025-08-07 16:30
Regulatory News Service
English 207.6 KB
2025-08-07 16:30
Legal Proceedings Report
English 21.0 KB
2025-07-16 12:29
Regulatory News Service
English 212.2 KB
2025-07-16 12:29
Earnings Release
English 7.7 KB
2025-06-30 15:29
Transaction in Own Shares
English 202.2 KB
2025-06-30 15:29
Transaction in Own Shares
English 1.4 MB
2025-06-30 15:29
Transaction in Own Shares
English 21.9 KB
2025-06-23 14:19
Director's Dealing
English 120.4 KB
2025-06-23 14:19
Transaction in Own Shares
English 167.5 KB
2025-06-23 14:19
Transaction in Own Shares
English 23.5 KB
2025-06-18 09:34
Share Issue/Capital Change
English 7.8 KB

Automate Your Workflow. Get a real-time feed of all Genmab filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genmab via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN